Abstract
COVID-19 pandemic has heightened the interest toward diagnosis and treatment of infectious diseases. Nuclear medicine, with its powerful scintigraphic, single photon emission computer tomography (SPECT), and positron emission tomography (PET) imaging modalities, has always played an important role in diagnosis of infections and distinguishing them from the sterile inflammation. In addition to the clinically available radiopharmaceuticals, there has been a decades-long effort to develop more specific imaging agents with some examples being radiolabeled antibiotics and antimicrobial peptides for bacterial imaging, radiolabeled antifungals for fungal infections imaging, radiolabeled pathogen-specific antibodies, and molecular engineered constructs. In this chapter, we discuss some examples of the work published in the last decade on develo** nuclear imaging agents for bacterial, fungal, and viral infections to generate more interest among nuclear medicine community toward conducting clinical trials of these novel probes, as well as toward develo** novel radiotracers for imaging infections.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Palestro CJ, Glaudemans A, Dierckx R (2013) Multiagent imaging of inflammation and infection with radionuclides. Clin Translat Imaging 1(6):385–396
Palestro CJ (2015) Radionuclide imaging of osteomyelitis. Semin Nucl Med 45(1):32–46
Chen W, Dilsizian V (2020) Molecular imaging of cardiovascular device infection: targeting the bacteria or the host-pathogen immune response? J Nucl Med 61(3):319–326
Sasser TA, Van Avermaete AE, White A et al (2013) Bacterial infection probes and imaging strategies in clinical nuclear medicine and preclinical molecular imaging. Curr Top Med Chem 13(4):479–487
Ebenhan T, Lazzeri E, Gheysens O (2018) Imaging of bacteria: is there any Hope for the future based on past experience? Curr Pharm Des 24(7):772–786
Naqvi SAR (2021) (99m)Tc-labeled antibiotics for infection diagnosis: mechanism, action, and progress. Chem Biol Drug Des. https://doi.org/10.1111/cbdd.13923
Halder KK, Nayak DK, Baishya R et al (2011) (99m)Tc-labeling of ciprofloxacin and nitrofuryl thiosemicarbazone using fac-[(99m)Tc(CO)3(H2O)3] core: evaluation of their efficacy as infection imaging agents. Metallomics 3(10):1041–1048
Fang S, Jiang Y, Gan Q et al (2020) Design, preparation, and evaluation of a novel (99m)TcN complex of ciprofloxacin xanthate as a potential bacterial infection imaging agent. Molecules 25(24). https://doi.org/10.3390/molecules25245837
Zhang S, Zhang W, Wang Y et al (2011) Synthesis and biodistribution of a novel ((9)(9)m)TcN complex of norfloxacin dithiocarbamate as a potential agent for bacterial infection imaging. Bioconjug Chem 22(3):369–375
Kakkar D, Tiwari AK, Chuttani K et al (2012) Design, synthesis, and antimycobacterial property of PEG-bis(INH) conjugates. Chem Biol Drug Des 80(2):245–253
Erfani M, Doroudi A, Hadisi L et al (2013) (99m)Tc-tricabonyl labeling of ofloxacin and its biological evaluation in Staphylococcus aureus as an infection imaging agent. J Label Comp Radiopharm 56(12):627–631
Mukherjee A, Sahoo S, Sarma HD et al (2014) Preparation and evaluation of three mucoadhesive dosage forms using (99m)Tc-Ofloxacin. Appl Radiat Isot 89:192–198
Kaul A, Hazari PP, Rawat H et al (2013) Preliminary evaluation of technetium-99m-labeled ceftriaxone: infection imaging agent for the clinical diagnosis of orthopedic infection. Int J Infect Dis 17(4):263–270
Hina S, Rajoka MI, Roohi S et al (2014) Preparation, biodistribution, and scintigraphic evaluation of (99m)Tc-clindamycin: an infection imaging agent. Appl Biochem Biotechnol 174(4):1420–1433
Ilem-Ozdemir D, Asikoglu M, Ozkilic H et al (2014) (99m) Tc-Doxycycline hyclate: a new radiolabeled antibiotic for bacterial infection imaging. J Label Comp Radiopharm 57(1):36–41
Ferreira Ddos S, Boratto FA, Cardoso VN et al (2015) Alendronate-coated long-circulating liposomes containing 99mtechnetium-ceftizoxime used to identify osteomyelitis. Int J Nanomedicine 10:2441–2450
Teixeira LE, Soares GG, Teixeira HC et al (2015) Efficacy of (99m)Tc-labeled ceftizoxime in the diagnosis of subclinical infections associated with titanium implants in rats. Surg Infect 16(3):352–357
Ilem-Ozdemir D, Asikoglu M, Ozkilic H et al (2016) Gamma scintigraphy and biodistribution of (99m)Tc-cefotaxime sodium in preclinical models of bacterial infection and sterile inflammation. J Label Comp Radiopharm 59(3):109–116
Sharma BG, Kumar N, Nishad DK et al (2016) Development of microbial trigger based oral formulation of Tinidazole and its gamma scintigraphy evaluation: a promising tool against anaerobic microbes associated GI problems. Eur J Pharm Sci 89:94–104
Ahmed MT, Naqvi SAR, Rasheed R et al (2017) Technetium-99m-labeled sulfadiazine: a targeting radiopharmaceutical for scintigraphic imaging of infectious foci due to Escherichia coli in mouse and rabbit models. Appl Biochem Biotechnol 183(1):374–384
Rasheed R, Naqvi SAR, Gillani SJH et al (2017) (99m) Tc-tazobactam, a novel infection imaging agent: Radiosynthesis, quality control, biodistribution, and infection imaging studies. J Label Comp Radiopharm 60(5):242–249
Iqbal A, Naqvi SAR, Rasheed R et al (2018) Radiosynthesis and biodistribution of (99m)Tc-Metronidazole as an Escherichia coli infection imaging radiopharmaceutical. Appl Biochem Biotechnol 185(1):127–139
Satpati D, Arjun C, Krishnamohan R et al (2016) (68)Ga-labeled ciprofloxacin conjugates as radiotracers for targeting bacterial infection. Chem Biol Drug Des 87(5):680–686
Northrup JD, Mach RH, Sellmyer MA (2019) Radiochemical approaches to imaging bacterial infections: intracellular versus extracellular targets. Int J Mol Sci 20(22). https://doi.org/10.3390/ijms20225808
Naqvi SAR, Drlica K (2017) Fluoroquinolones as imaging agents for bacterial infection. Dalton Trans 46(42):14452–14460
Wang H, Lu Y, Liu L et al (2014) Radiosynthesis and biological evaluation of a novel enoyl-ACP reductase inhibitor for Staphylococcus aureus. Eur J Med Chem 88:66–73
Mota F, Jadhav R, Ruiz-Bedoya CA et al (2020) Radiosynthesis and biodistribution of (18)F-Linezolid in Mycobacterium tuberculosis-infected mice using positron emission tomography. ACS Infect Dis 6(5):916–921
Liu L, Xu Y, Shea C et al (2010) Radiosynthesis and bioimaging of the tuberculosis chemotherapeutics isoniazid, rifampicin and pyrazinamide in baboons. J Med Chem 53(7):2882–2891
Esteves PJ, Abrantes J, Baldauf HM et al (2018) The wide utility of rabbits as models of human diseases. Exp Mol Med 50(5):1–10
Ebenhan T, Gheysens O, Kruger HG et al (2014) Antimicrobial peptides: their role as infection-selective tracers for molecular imaging. Biomed Res Int 2014:867381. https://doi.org/10.1155/2014/867381
Kamaleshwaran KK, Rajkumar N, Mohanan V et al (2015) 99m-Tc-ubiquicidin scintigraphy in diagnosis of knee prosthesis infection and comparison with F-18 fluorodeoxy-glucose positron emission tomography/computed tomography. Indian J Nucl Med 30(3):259–262. https://doi.org/10.4103/0972-3919.158540
Auletta S, Baldoni D, Varani M et al (2019) Comparison of 99mTc-UBI 29-41, 99mTc-ciprofloxacin, 99mTc-ciprofloxacin dithiocarbamate and 111In-biotin for targeting experimental Staphylococcus aureus and Escherichia coli foreign-body infections: an ex-vivo study. Q J Nucl Med Mol Imaging 63(1):37–47
Ebenhan T, Sathekge MM, Lengana T et al (2018) (68)Ga-NOTA-functionalized Ubiquicidin: cytotoxicity, biodistribution, radiation dosimetry, and first-in-human PET/CT imaging of infections. J Nucl Med 59(2):334–339
Boddeti DK, Kumar V (2021) Evaluation of (68)Ga-DOTA-Ubiquicidin (29-41) for imaging Staphylococcus aureus (Staph A) infection and turpentine-induced inflammation in a preclinical setting. World J Nucl Med 20(3):266–272
Mazaheri Tehrani M, Erfani M, Amirmozafari N (2021) [(99m) Tc-HYNIC/EDDA]-MccJ25 antimicrobial peptide analog as a potential radiotracer for detection of infection. Chem Biol Drug Des 97(4):904–913
Follacchio GA, Pala A, Scaccianoce S et al (2019) In vivo microbial targeting of 99mTc-labeled human beta-Defensin-3 in a rat model of infection. Clin Nucl Med 44(11):602–e606
Aweda TA, Muftuler ZFB, Massicano AVF et al (2019) Radiolabeled cationic peptides for targeted imaging of infection. Contrast Media Mol Imaging 2019:3149249. https://doi.org/10.1155/2019/3149249
Chopra S, Singh B, Koul A et al (2019) Radiosynthesis and pre-clinical evaluation of [68Ga] labeled antimicrobial peptide fragment GF-17 as a potential infection imaging PET radiotracer. Appl Radiat Isot 149:9–21
Weinstein EA, Ordonez AA, DeMarco VP et al (2014) Imaging Enterobacteriaceae infection in vivo with 18F-fluorodeoxysorbitol positron emission tomography. Sci Transl Med. https://doi.org/10.1126/scitranslmed.3009815
Namavari M, Gowrishankar G, Hoehne A et al (2015) Synthesis of [18F]-labelled maltose derivatives as PET tracers for imaging bacterial infection. Mol Imaging Biol 17:168–176
Gowrishankar G, Hardy J, Wardak M et al (2017) Specific imaging of bacterial infection using 6 -18F-Fluoromaltotriose: a second-generation PET tracer targeting the Maltodextrin Transporter in bacteria. J Nucl Med 58:1679–1684
Shukla J, Arora G, Kotwal PP et al (2010) Radiolabeled oligosaccharides nanoprobes for infection imaging. Hell J Nucl Med 13(3):218–223
Pickett JE, Thompson JM, Sadowska A et al (2018) Molecularly specific detection of bacterial lipoteichoic acid for diagnosis of prosthetic joint infection of the bone. Bone Res 6:13–18
Foss CA, Kulik L, Ordonez AA et al (2019) SPECT/CT imaging of Mycobacterium tuberculosis infection with [(125)I]anti-C3d mAb. Mol Imaging Biol 21(3):473–481
Thornton CR (2020) Detection of the ‘Big Five’ mold killers of humans: Aspergillus, Fusarium, Lomentospora, Scedosporium and Mucormycetes. Adv Appl Microbiol 110:1–61
Page L, Ullmann AJ, Schadt F et al (2020) In vitro evaluation of radiolabeled amphotericin B for molecular imaging of mold infections. Antimicrob Agents Chemother 64(7):AAC.02377-19
Haas H, Petrik M, Decristoforo C (2015) An iron-mimicking, Trojan horse-entering fungi—has the time come for molecular imaging of fungal infections? PLoS Pathog 11:e1004568. https://doi.org/10.1371/journal.ppat.1004568
Petrik M, Haas H, Laverman P et al (2014) 68Ga-triacetylfusarinine C and 68Ga-ferrioxamine E for Aspergillus infection imaging: uptake specificity in various microorganisms. Mol Imaging Biol 16:102–108
Davies G, Rolle AM, Maurer A et al (2017) Towards translational ImmunoPET/MR imaging of invasive pulmonary Aspergillosis: the humanised monoclonal antibody JF5 detects Aspergillus lung infections in vivo. Theranostics 7(14):3398–3414
Henneberg S, Hasenberg A, Maurer A et al (2021) Antibody-guided in vivo imaging of Aspergillus fumigatus lung infections during antifungal azole treatment. Nat Commun 12(1):1707–1711
Schwenck J, Maurer A, Beziere N et al (2022) Antibody-guided molecular imaging of Aspergillus lung infections in Leukemia patients. J Nucl Med. jnumed.121.263251
Woodham AW, Zeigler SH, Zeyang EL et al (2020) In vivo detection of antigen-specific CD8(+) T cells by immuno-positron emission tomography. Nat Methods 17(10):1025–1032
Song J, Cai Z, White AG et al (2015) Visualization and quantification of simian immunodeficiency virus-infected cells using non-invasive molecular imaging. J Gen Virol 96(10):3131–3142
Santangelo PJ, Rogers KA, Zurla C et al (2015) Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy-treated macaques. Nat Methods 12(5):427–432
Tsukrov D, McFarren A, Morgenstern A et al (2016) Combination of antiretroviral drugs and radioimmunotherapy specifically kills infected cells from HIV-infected individuals. Front Med (Lausanne) 3:41. https://doi.org/10.3389/fmed.2016.00041
Beckford-Vera DR, Flavell RR, Seo Y et al (2022) First-in-human immunoPET imaging of HIV-1 infection using 89Zr-labeled VRC01 broadly neutralizing antibody. Nat Commun 13(1):1219–1223
Rodríguez-Alfonso B, Ruiz Solís S, Silva-Hernández L et al (2021) (18)F-FDG-PET/CT in SARS-CoV-2 infection and its sequelae. Rev Esp Med Nucl Imagen Mol (Engl Ed) 40(5):299–309
Casali M, Lauri C, Altini C et al (2021) State of the art of (18)F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation. Clin Translat Imaging 10:1–41
Das JP, Yeh R, Schöder (2021) Clinical utility of perfusion (Q)-single-photon emission computed tomography (SPECT)/CT for diagnosing pulmonary embolus (PE) in COVID-19 patients with a moderate to high pre-test probability of PE. Eur J Nucl Med Mol Imaging 48(3):794–799
Dadachova E, Berman JW (2015) Non-invasive nuclear imaging for localization of viral reservoirs. Nat Methods 12(5):399–400
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Dadachova, E., Rangel, D.E.N. (2024). Recent Advancements in Radiopharmaceuticals for Infection Imaging. In: Thakur, A. (eds) Intracellular Pathogens. Methods in Molecular Biology, vol 2813. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3890-3_14
Download citation
DOI: https://doi.org/10.1007/978-1-0716-3890-3_14
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-3889-7
Online ISBN: 978-1-0716-3890-3
eBook Packages: Springer Protocols